The Seed Investor News Roundup

Read our Investor Dashboard on OTC:ABCCF TSX.v ABCN

There will be a sudden wave of "Marijuana Millionaires" in 2017 - will you be one?

Read the Investors Guide To Newly Emerging Marijuana Markets

Tilray® Signs Supplier Agreement with Shoppers Drug Mart

Tilray Canada Ltd. announced today that it has entered into an agreement to become a medical cannabis supplier to Shoppers Drug Mart.

Nuuvera and Aphria finalize offtake agreement for extra 60,000 kgs of cannabis production

Nuuvera Inc. (TSXV: NUU) and Aphria Inc. (TSX: APH & US OTC QB: APHQF) announced today that they have executed a previously announced definitive offtake agreement for 60,000 kgs of cannabis production.

Canopy Growth Corporation Announces Increase to Bought Deal Financing

Canopy Growth Corporation (TSX:WEED) is pleased to announce that, due to strong demand, it has agreed with a syndicate of underwriters co-led by GMP Securities L.P. and BMO Capital Markets as joint bookrunners, and including Canaccord Genuity Corp., Eight Capital, Beacon Securities Limited, and PI Financial Corp., to increase the size of its previously announced $175,076,000 bought deal offering.

Please see full disclaimers on the TheSeedInvestor.com website applicable to all content provided by TSI, wherever published or re-published: http://theseedinvestor.com/about/disclaimerDisclaimer.

This news release/advertorial is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. It is possible that a viewer’s entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed on this website unless you can afford to lose your entire investment. Also, investing in small-cap and micro-cap securities is highly speculative and carries an extremely high degree of risk. This website makes no recommendation that the securities of the companies profiled or discussed on this website should be purchased, sold or held by viewers that learn of the profiled companies through our website. Compensation: A thirty-six-thousand-dollar investor relations budget is being managed by The Seed Investor. Any funds leftover after expenses for research, overhead, advertising and public relations related to InMed Pharmaceuticals Inc. (ticker symbol (CSE: IN; OTCQB: IMLFF) will be considered profit. The Seed Investor and/or entities related to The Seed Investor hold shares in (CSE: IN; OTCQB: IMLFF) and intend to sell those shares. Please review all investment decisions with a licensed investment advisor.

TheSeedInvestor.com
9375 E Shea Blvd Ste 100
Scottsdale 85260

info@theseedinvestor.com

To keep receiving emails from us, please add us to your address book.